Robert H. Lurie Comprehensive Cancer Center
Hematology
Dr. Leo Gordon, MD
|
|
Give Review
Gordon practices Hematology. He went to medical school at University of Cincinnati College of Medicine. He has 4 awards "Meaningful Use Stage 1 Certification", "Fellow (FACP)", "Top MD" and "Super Doctor". Dr. Leo Gordon has written publications. He has 41 publications published with PubMed. The lastest paper is: 'Bevacizumab for recurrent primary central nervous system lymphoma: a new treatment?' He is registered with Medicare and accepts Medicare payments.
Publications
- Bevacizumab for recurrent primary central Nervous system lymphoma: a new treatment?
- Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin Lymphoma in the modern era.
- Common variants of the G protein-coupled receptor type 4 are associated with human essential hypertension and predict the blood pressure response to angiotensin recept...
- Synthetic high-density lipoprotein-like nanoparticles for Cancer therapy.
- Radiation for diffuse large B-cell lymphoma in the rituximab era: Analysis of the National Comprehensive Cancer Network lymphoma outcomes project.
- Blocking tumor escape in hematologic malignancies: The anti-PD-1 strategy.
- Pidilizumab in the treatment of diffuse large B-cell Lymphoma.
- Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic Leukemia: short- and long-term outcomes.
- Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-hodgkin Lymphoma: a multicentre phase II study.
- Recent advances in mantle cell Lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium Workshop.
- Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network.
- F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-Cell transplantation for relapsed and refractory Hodgkin lym...
- Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: ...
- Transformed non-Hodgkin lymphoma in the rituximab era: Analysis of the NCCN outcomes database.
- An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell Lymphoma treated in the rituximab era.
- MDCT of Chest, Abdomen, and Pelvis Using Attenuation-Based Automated Tube Voltage Selection in Combination With Iterative Reconstruction: An Intrapatient Study of Radi...
- Patterns of use of 18-fluoro-2-deoxy-D-glucose positron emission tomography for initial staging of grade 1-2 follicular Lymphoma and its impact on initial treatment st...
- Recent advances in mantle cell Lymphoma: report of the 2012 Mantle Cell Lymphoma Consortium Workshop.
- Lymphoma Occurring During Pregnancy: Antenatal Therapy, Complications, and Maternal Survival in a Multicenter Analysis.
- Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: A comprehensive Analysis from the NCCN lymphoma outcomes project.
- A phase I/II trial of Bortezomib combined concurrently with Gemcitabine for relapsed or refractory DLBCL and peripheral T-cell Lymphomas.
- Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative Analysis from a large North American co-operative group trial.
- Haematological Cancer: Indolent lymphoma-why not to sprint at the start of a marathon.
- Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era.
- Nano-Encapsulation of Arsenic Trioxide Enhances Efficacy against Murine Lymphoma Model while Minimizing Its Impact on Ovarian Reserve In Vitro and In Vivo.
- Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin Lymphoma: a phase I trial of combined indu...
- Biomimetic, synthetic HDL nanostructures for Lymphoma.
- Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Co...
- The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive Analysis from the N...
- Genetic heterogeneity of diffuse large B-cell Lymphoma.
- Mitochondrial-Mediated Apoptosis in Lymphoma Cells by the Diterpenoid Lactone Andrographolide, the Active Component of Andrographis paniculata.
- Curcumin nanodisks: formulation and characterization.
- Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs.
- Radioimmunotherapy for the treatment of non-Hodgkin Lymphoma: current status and future applications.
- All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell Lymphoma.
- The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular Lymphoma: an evidence-based review.
- Motexafin gadolinium enhances p53-Mdm2 interactions, reducing p53 and downstream targets in Lymphoma cell lines.
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports ...
- Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent Lymphoma: results of the randomized p...
- Yttrium-90 ibritumomab tiuxetan doses calculated to deLiver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in...
Schools
University Of Cincinnati College Of Medicine
University Chicago Hosps
University Minn Hosps
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- Assurant Health
- Bakery & Confectionary Union Plan
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- Health and Life PPO
- Platinum PPO
- First Health (Coventry Health Care) PPO
- Golden Rule
- Guardian
- HealthLink PPO
- Choice Care PPO
- Medicare MCR
- Medico
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Pipefitters
- Priority Health
- Tricare
- Choice Plus POS
- Options PPO
- United Healthcare
Awards
- Meaningful Use Stage 1 Certification
- Fellow (FACP)
- Top MD
- Super Doctor
Education
-
University of Chicago -
University of Cincinnati College of Medicine
Hospital
-
Northwestern Memorial Hospital -
Lurie Children's Hospital of Chicago
Drug Facts
| NPI NUMBER | 1821028499 | |
| NPPES Provider LastName | GORDON | |
| NPPES Provider FirstName | LEO | |
| NPPES Provider ZIPCode | 606115975 | |
| NPPES Provider State | IL | |
| Specialty Description | Hematology | |
| Total Claim Count | 394.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1821028499 |
| Last Name Of The Provider | GORDON |
| First Name Of The Provider | LEO |
| View All |
Similar Doctors
|
|
Dr. Paul G. Rubinstein, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Pawan Gundavaram, MD |
|
|
Dr. Seema Singhal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Reza M. Mostofi, MD |
|
|
Dr. Thomas E. Lad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thiti Jaojaroenkul, MD |
|
|
Dr. Amy Chadburn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rosalind Catchatourian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elias I. Obeid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irum H. Khan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dominic S. Ho, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yi Hua Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Olga Zuk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sigmund A. Weitzman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joyce Samuel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kalid N. Adab, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manali A. Bhave, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bobby Chawla, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristen M. Pettit, MD |
|
|
Dr. Hiral A. Shah, MD |
|
|
Dr. Luis D. Sumoza, MD |